Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Full Face Dysport Applications
NCT01032954Phase 4Completed
- Sponsor
- Hexsel Dermatology Clinic
- Start
- Nov 2009
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in rhytides, sponsored by Hexsel Dermatology Clinic. Started Nov 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT01032954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032954.